Our program has active clinical trials in acute pancreatitis, pancreatic cystic disorders, pancreatic genetic disorders, and other conditions involving the pancreas. These studies are supported by the National Institute of Health (NIH) and other resources.
Comparing the clinical impact of pancreatic cyst surveillance programs – Site PI: Richard Kwon, MD, MS
Double-blind, randomized, parallel design with 2 dose cohorts of pancrelipase (CREON) in resected pancreatic cancer subjects and an open-label single dose cohort in non-resected pancreatic cancer subjects – Site PI: Richard Kwon, MD, MS
Pancreatic Cancer Early Detection (PRECEDE) Consortium – Site PI: Richard Kwon, MD, MS
Cancer of the Pancreas Screening-5 (CAPS5) – Site PI: Elena Stoffel, MD, MPH
Detection of biomarkers of pancreatic cancer – PI: Michelle Anderson, MD, MS
Stent vs. indomethacin for preventing post-ERCP pancreatitis: The SVI trial – Site PI: Richard Kwon, MD, MS
Longitudinal study of pancreatic cystic lesions with endoscopic ultrasound – PI: Richard Kwon, MD, MS
A prospective multicenter cohort study evaluating the association between competency in trainees and clinical outcomes in ERCP: The ACT-ERCP study – PI: Richard Kwon, MD, MS
Results of ERCP in sphincter of Oddi dysfunction: The RESPOnD study – PI: Richard Kwon, MD, MS
To learn more, visit umhealthresearch.org.